Table 3:
Multivariable Adjusted Associations of Hormonal Contraceptive Type with AMH Among Current Users Compared to Never Users
| N | AMH, ng/mL Median (IQR) | Estimate of % change in AMH (95% CI) | |
|---|---|---|---|
| Never use | 232 | 4.71 (2.92, 7.19) | Reference |
| COC | 180 | 3.54 (2.01, 5.97) | −24.0% (−36.6%, −8.9%) |
| Ring | 28 | 1.89 (1.38, 3.91) | −64.8% (−75.4%, −49.6%) |
| DMPA | 103 | 3.23 (1.92, 5.72) | −26.7% (−41.0%, −8.9%) |
| LNG-IUD | 116 | 3.89 (2.46, 6.15) | −8.7% (−25.7%, 12.2%) |
COC=combined oral contraceptives, DMPA=depot medroxyprogesterone acetate, LNG-IUD=levonorgestrel IUD The multivariable model adjusted for age, age2, BMI, and reported histories of PCOS, abnormal menstrual bleeding, thyroid condition, and seeking care for difficulty conceiving